Using innovative methods to measure changes in muscle, a team has shown that after treatment three young boys with DMD had considerably lower fat infiltration in their muscles than boys receiving standard treatment.
The Myology Institute hosted its inaugural members retreat and Marty Kushmerick Memorial Lecture on Friday, March 6th. For those who were not able to attend, please click the link below to view the lecture.
So-called gene doping is banned in sports, but some philosophers argue that it’s the way of the future
Researchers from across the globe gathered in the Reitz Union at the University of Florida for a three-day muscle biology conference last week.
Just 20 years ago, scientists didn’t even realize muscles had their own circadian clocks. Now they are beginning to appreciate their importance in health.
At the American Academy of Neurology 70th Annual meeting in Los Angeles on April 25, it was reported that the drug edasalonexent showed a remarkably favorable impact on the progression of Duchenne muscular dystrophy in 4- to 7-year-old boys (“MoveDMD trial”).
A pair of protein-inhibiting compounds is effective at slowing the progression of a form of muscular dystrophy in animal models, a group of University of Florida Health researchers has found.
The University of Florida welcomed more than 300 researchers from around the world for the Advances in Skeletal Muscle Biology in Health and Disease conference March 8-10 in Gainesville
When we exercise, a cascade of benefits occurs, but researchers don’t know exactly what happens in the body to cause those benefits. Now, two teams at the University of Florida have received a total of approximately $11.6 million out of a $170 million push from the National Institutes of Health to study the molecular changes that occur during physical activity.
A year after it was formed, the UF Myology Institute is gaining strength in the world of muscle biology research.
University of Florida Health has been designated by the National Institutes of Health as one of six centers to help translate scientific findings into strategies to improve the lives of muscular dystrophy patients. UF Health has received first-year funding of a 5-year, $10.76 million grant to study ways to address muscle degeneration caused by the disease.
The Department of Pharmacology is honored to welcome Dr. H. Lee Sweeney to the faculty. Dr. Sweeney will join the department as The Thomas H. Maren, M.D., Eminent Scholar Chair. Dr. Sweeney will also serve as Director of the UF Myology Institute.